Magnet Ventures

LiliumX discovers new bispecific antibodies against cancer by utilizing a protein technology platform to facilitate the scalable discovery of first-in-class bispecific biologics.

Atom Bioworks is a biotechnology company that focuses on developing a pattern-recognition-enabled platform for sensing and therapeutic applications targeting infectious diseases and cancer. By utilizing advanced methodologies in computational biology, quantum chemistry, software, and machine learning, the company captures the surface protein patterns associated with diseases. This innovative approach allows for the creation of pattern-matching constructs, providing researchers with enhanced capabilities in nano-pattern recognition. Atom Bioworks aims to facilitate early diagnosis and treatment, thereby contributing to advancements in medical applications.

Regard offers an AI-driven platform that enhances hospital operations by assisting in diagnoses, reducing coding queries, and streamlining patient care processes. It benefits various stakeholders within the healthcare system.

Flux Biosciences is a company that originated from Stanford University, leveraging technology initially developed for reading and writing computer hard drives to create advanced point-of-care in vitro medical diagnostics. Its portable biosensor platform allows for the measurement of various biomarkers found in blood, urine, or saliva, providing insights related to exercise, stress, fertility, and diet. The biosensors are designed to detect specific biomarkers through real-time interactions with magnetic nanoparticles, enabling the simultaneous measurement of multiple markers from a single sample. By integrating data from these measurements with sleep and activity information from wearable devices, Flux Biosciences aims to empower individuals to manage their health and lifestyle choices more effectively, making medical-grade diagnostics accessible and actionable within the home.

Flux Biosciences is a company that originated from Stanford University, leveraging technology initially developed for reading and writing computer hard drives to create advanced point-of-care in vitro medical diagnostics. Its portable biosensor platform allows for the measurement of various biomarkers found in blood, urine, or saliva, providing insights related to exercise, stress, fertility, and diet. The biosensors are designed to detect specific biomarkers through real-time interactions with magnetic nanoparticles, enabling the simultaneous measurement of multiple markers from a single sample. By integrating data from these measurements with sleep and activity information from wearable devices, Flux Biosciences aims to empower individuals to manage their health and lifestyle choices more effectively, making medical-grade diagnostics accessible and actionable within the home.